| Mckenzie B Tucker, DO | |
|
1413 N Elm St Ste 201, Henderson, KY 42420-2767 | |
| (270) 827-8662 | |
| (270) 826-8220 |
| Full Name | Mckenzie B Tucker |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 1413 N Elm St Ste 201, Henderson, Kentucky |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215596036 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 11020485A (Indiana) | Primary |
| 207Q00000X | Family Medicine | 05137 (Kentucky) | Secondary |
| Entity Name | Deaconess Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891941688 PECOS PAC ID: 3375610116 Enrollment ID: O20081017000259 |
News Archive
In response to recent actions of the U.S. National Science Advisory Board for Biosecurity (NSABB), which recommended that two scientific journals withhold crucial details in upcoming reports about experiments with a novel strain of the bird flu virus, H5N1, the American Society for Microbiology (ASM) will publish a special series of commentaries by prominent scientists, including the acting chair of the NSABB, weighing in on whether the recommendations were necessary and what role biosecurity considerations should play in the dissemination of research findings.
Abdominal aortic aneurysm (AAA) - a condition in which the large vessel that supplies blood to your abdomen, legs, and pelvis swells to over 50 percent its normal size -occurs in approximately 4 out of 100 adults.
CANCER RESEARCH UK is set to extend its drug discovery effort by investing up to £16 million in two new Drug Discovery Programmes at the Paterson Institute for Cancer Research in Manchester and the Beatson Institute for Cancer Research in Glasgow.
It is estimated that 1 in 500 children will be diagnosed with a form of childhood cancer. Fortunately, with the use of aggressive treatment modalities, more than 75% of these children will be cured. Therefore, many of these children and parents are looking beyond the cancer at important quality of life issues and guiding their treatments to assure "normal" post-cancer survivorship.
The Phase I trial of ADXS11-001, the lead vaccine candidate of Advaxis, Inc., the company that pioneered the live, attenuated Listeria monocytogenes (Lm) vaccine, has shown thirty-six (36) month survival in two (2) of the thirteen (13) evaluable patients treated with Advaxis' therapeutic cancer vaccine, indicating the possibility of persistent immune protection, from only a two (2) dose initial regimen.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mckenzie B Tucker, DO Po Box 1510, Evansville, IN 47706-1510 Ph: (812) 450-6815 | Mckenzie B Tucker, DO 1413 N Elm St Ste 201, Henderson, KY 42420-2767 Ph: (270) 827-8662 |
News Archive
In response to recent actions of the U.S. National Science Advisory Board for Biosecurity (NSABB), which recommended that two scientific journals withhold crucial details in upcoming reports about experiments with a novel strain of the bird flu virus, H5N1, the American Society for Microbiology (ASM) will publish a special series of commentaries by prominent scientists, including the acting chair of the NSABB, weighing in on whether the recommendations were necessary and what role biosecurity considerations should play in the dissemination of research findings.
Abdominal aortic aneurysm (AAA) - a condition in which the large vessel that supplies blood to your abdomen, legs, and pelvis swells to over 50 percent its normal size -occurs in approximately 4 out of 100 adults.
CANCER RESEARCH UK is set to extend its drug discovery effort by investing up to £16 million in two new Drug Discovery Programmes at the Paterson Institute for Cancer Research in Manchester and the Beatson Institute for Cancer Research in Glasgow.
It is estimated that 1 in 500 children will be diagnosed with a form of childhood cancer. Fortunately, with the use of aggressive treatment modalities, more than 75% of these children will be cured. Therefore, many of these children and parents are looking beyond the cancer at important quality of life issues and guiding their treatments to assure "normal" post-cancer survivorship.
The Phase I trial of ADXS11-001, the lead vaccine candidate of Advaxis, Inc., the company that pioneered the live, attenuated Listeria monocytogenes (Lm) vaccine, has shown thirty-six (36) month survival in two (2) of the thirteen (13) evaluable patients treated with Advaxis' therapeutic cancer vaccine, indicating the possibility of persistent immune protection, from only a two (2) dose initial regimen.
› Verified 2 days ago
Michael A Roof, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 1305 N Elm St, Henderson, KY 42420 Phone: 270-827-7700 | |
Sheri Dawn Montgomery, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1305 N Elm St, Er, Henderson, KY 42420 Phone: 800-467-7766 | |
Kerry Conrad Gusler, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1305 N Elm St, Henderson, KY 42420 Phone: 270-827-7700 | |
Dr. David A Watkins, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1015 N Elm St, Henderson, KY 42420 Phone: 270-826-8009 Fax: 270-826-7010 | |
Nhan Huu Nguyen, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1015 North Elm Street, Henderson, KY 42420 Phone: 270-826-8009 Fax: 270-826-7010 | |
Gerri L Moore, ARNP Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 340 Starlite Dr, Henderson, KY 42420 Phone: 270-844-8515 Fax: 270-844-8183 |